Male patients with group 3 pulmonary hypertension (PH) have worse right ventricular (RV) function compared with female patients, according to…
Articles by Santiago Gisler
Doctors in the Netherlands are using the VMS Heart Analysis System, developed by Ventripoint Diagnostics, for early diagnosis of…
Tracleer (bosentan) treatment improves mean pulmonary arterial pressure (mPAP) in β-thalassemia patients with potential pulmonary arterial hypertension…
Higher levels of certain high-density lipoproteins (HDLs) improve the survival of pulmonary arterial hypertension (PAH) patients, according to a recent…
Analytics 4 Life and Actelion Pharmaceuticals have announced a collaboration agreement to test CorVista as a potential…
Low diffusing capacity of the lung for carbon monoxide (DLCO) is a key indicator of mortality in group 3 pulmonary…
Biotechnology company Morphogen-IXÂ recently announced that it will be further developing MGX292 as its treatment candidate for pulmonary arterial…
A receptor protein present in immune cells is a potential target for treating pulmonary hypertension (PH), according to a new…